about
Chemotherapy Induces Oral Mucositis in Mice Without Additional Noxious Stimuli.Experimental Models of C. albicans-Streptococcal Co-infection.S. oralis activates the Efg1 filamentation pathway in C. albicans to promote cross-kingdom interactions and mucosal biofilms.Streptococcus oralis and Candida albicans Synergistically Activate μ-Calpain to Degrade E-cadherin From Oral Epithelial Junctions.Candida-streptococcal mucosal biofilms display distinct structural and virulence characteristics depending on growth conditions and hyphal morphotypes.Effect of serine-type protease of Candida spp. isolated from linear gingival erythema of HIV-positive children: critical factors in the colonization.The effect of poly(methyl methacrylate) surface treatments on the adhesion of silicone-based resilient denture liners.Resins-based denture soft lining materials modified by chlorhexidine salt incorporation: an in vitro analysis of antifungal activity, drug release and hardness.A three-species biofilm model for the evaluation of enamel and dentin demineralization.Chemotherapy-induced oral mucositis and associated infections in a novel organotypic model.Effect of daily use of an enzymatic denture cleanser on Candida albicans biofilms formed on polyamide and poly(methyl methacrylate) resins: an in vitro study.Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infectionThe use of CAD/CAM technology to fabricate a custom ceramic implant abutment: a clinical reportAntibacterial photocatalytic activity of different crystalline TiO2 phases in oral multispecies biofilmDoes traumatic occlusal forces lead to peri-implant bone loss? A systematic reviewTitanium particles and ions favor dysbiosis in oral biofilms
P50
Q38664413-1E28B5AB-9C65-4A5C-93A4-D00F3F114555Q38823418-C85CEF85-5F60-45A7-AC05-7BE0ED9DF4D7Q40222061-A32AC74C-B24D-480E-AD7E-F505DF1FAC6AQ40670545-28B30503-4C6E-4357-A774-6097E8DDE0F2Q41440671-BA108266-6050-4D1A-A799-9ACDC21666D0Q42974903-8530EAA9-1852-4A3D-BFC0-B944679DFA1FQ44941393-2456C9B8-C543-4164-9CAE-63903B8A415EQ45984415-86C1EC37-9B40-43E8-AF30-BAEF4C061B43Q46905915-07D8A122-813A-4FBE-AE7D-95DA35AB879FQ50122358-B60E18A3-2400-4BEE-A7EC-8116DE723FECQ53016447-2CA107E2-B9EB-4219-926C-C3BF3A849CC2Q64099639-266C6F7D-D19A-417A-B302-AC4A33B213F4Q87112366-AE421D73-D2DA-47DB-A41E-73796E2FF6A5Q88424833-A60623E0-FBFB-4247-96B9-903130575681Q90432903-DD5714E3-3B0C-426B-AD3B-B80A6CD6EF23Q91423755-3266F0C0-3B5B-4F58-86E4-FB697775B067
P50
description
investigador
@es
researcher
@en
name
Martinna Bertolini
@en
type
label
Martinna Bertolini
@en
prefLabel
Martinna Bertolini
@en
P31
P496
0000-0003-3619-6618